Poststroke Epilepsy Risk Varies With Antihypertensive Treatment
Risk for PSE was lower for patients treated with ARBs and higher for those receiving calcium channel blockers, beta-blockers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.